HomeTagsNeuroSense Therapeutics

NeuroSense Therapeutics

Biotechnology

NeuroSense Receives Regulatory Approval to Commence Patient Enrollment in Italy

PR Newswire - November 17, 2022

NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, announced it has received approval from the Italian Medicines Agency (AIFA) to commence...

Biotechnology

NeuroSense Therapeutics Receives $4 Million Through Warrant Exercises

PR Newswire - March 28, 2022

NeuroSense Therapeutics Ltd. ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, announced it has received proceeds of approximately $4 million from the exercise...

Hot Topics

Red Hat and Deloitte Collaborate to Propel Software-Defined Vehicles with Pre-Integrated Solutions

AV’s Switchblade 600 Selected for Tranche 1 of the U.S. Department of Defense’s Replicator Initiative

delaPlex and Cycle Labs Deepen Strategic Partnership to Transform Testing as a Service

Red Hat and Deloitte Collaborate to Propel Software-Defined Vehicles with Pre-Integrated…

AV’s Switchblade 600 Selected for Tranche 1 of the U.S. Department…

delaPlex and Cycle Labs Deepen Strategic Partnership to Transform Testing as…

IT Infrastructure Management: A Comprehensive Overview

NeuroSense Therapeutics

Hot Topics

Red Hat and Deloitte Collaborate to Propel Software-Defined Vehicles with Pre-Integrated Solutions

AV’s Switchblade 600 Selected for Tranche 1 of the U.S. Department of Defense’s Replicator Initiative

delaPlex and Cycle Labs Deepen Strategic Partnership to Transform Testing as a Service